- Home
- UHAL vs PRME Comparison
UHAL vs PRME Comparison
Compare UHAL & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UHAL | PRME |
|---|---|---|
| Founded | 1945 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 601.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | UHAL | PRME |
|---|---|---|
| Price | $53.50 | $4.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.31 |
| AVG Volume (30 Days) | 196.8K | ★ 3.7M |
| Earning Date | 11-05-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.19 | N/A |
| Revenue | ★ $5,972,459,000.00 | $5,977,000.00 |
| Revenue This Year | $6.61 | $111.80 |
| Revenue Next Year | $4.20 | N/A |
| P/E Ratio | $45.01 | ★ N/A |
| Revenue Growth | 5.86 | ★ 647.13 |
| 52 Week Low | $48.48 | $1.11 |
| 52 Week High | $75.19 | $6.94 |
Technical Indicators
Market Signals| Indicator | UHAL | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 53.41 | 52.01 |
| Support Level | $50.83 | $3.95 |
| Resistance Level | $55.43 | $4.42 |
| Average True Range (ATR) | 1.38 | 0.30 |
| MACD | 0.36 | 0.12 |
| Stochastic Oscillator | 65.44 | 76.72 |
Price Performance
Historical ComparisonAbout UHAL U-Haul Holding Company
U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.